McKesson recalls Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRI
Recalled February 5, 2025 · FDA recall D-0213-2025 · McKesson
Hazard
cGMP Deviations: Product intended for quarantine was inadvertently distributed. · FDA Class II
Units
192 vials
Sold at
Nationwide USA
Description
cGMP Deviations: Product intended for quarantine was inadvertently distributed.
Product
Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01
Manufacturer(s)
McKesson
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →